Tokyo, Nov. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063655) titled 'Effects of 8-week intake of cocoa flavanol-containing food on skin condition' on Nov. 17.

Study Type: Interventional

Study Design: Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponsor: Institute - PlasMEDi Inc.

Condition: Condition - Healthy Japanese Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the efficacy and safety of the intake of cocoa flavanol-containing food on skin condition (stratum corneum hydration, trans epidermal water loss, wrinkles, pigmentation, etc.). Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Intake of cocoa flavanol-containing food (chocolate) once daily for 8 consecutive weeks

Eligibility: Age-lower limit - 30 years-old = Gender - Female Key inclusion criteria - 1. Healthy Japanese females aged 30 to 65 years at the time of obtaining informed consent. 2. Individuals who are aware of skin dryness, wrinkles, or dullness (pigmentation), or who wish to improve these conditions. 3. Individuals who have received a sufficient explanation regarding study participation, fully understand the details, and voluntarily provide written informed consent. Key exclusion criteria - 1.Individuals with a history of atopic dermatitis, or who are currently undergoing treatment for it. 2.Individuals with a history of, or currently receiving treatment for (including continuous medication use), serious diseases (such as cardiovascular, hepatic, renal, or gastrointestinal diseases) or lifestyle-related diseases (such as hypertension, diabetes, or dyslipidemia). 3.Individuals with skin disorders on the test site (face) that may interfere with the evaluation of study results (e.g., eczema, severe sunburn, severe acne). 4.Individuals with a history of hypersensitivity, allergy, or severe adverse reactions to chocolate or ingredients of the test product (milk, soy, wheat, egg, and cashew nut). 5.Individuals who routinely use or ingest medicines or dietary supplements aimed at improving skin conditions, and who cannot discontinue them during the study period. 6.Females who are pregnant, suspected of being pregnant, or lactating. 7.Individuals who have undergone aesthetic medical treatments on the face (e.g., laser therapy, light therapy, chemical peels, injectable treatments) within 3 months prior to the eligibility assessment, or who plan to undergo such treatments during the study period. 8.Individuals who have participated in other clinical trials (interventional studies) within 3 months prior to the eligibility assessment, or who plan to participate in other trials during this study period. 9.Other individuals deemed ineligible for participation in this study by the principal investigator or study director. Target Size - 15

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 10 Month 09 Day Anticipated trial start date - 2026 Year 11 Month 18 Day Last follow-up date - 2027 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072705

Disclaimer: Curated by HT Syndication.